...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis of novel fluconazoliums and their evaluation for antibacterial and antifungal activities.
【24h】

Synthesis of novel fluconazoliums and their evaluation for antibacterial and antifungal activities.

机译:新型氟康唑的合成及其对抗菌和抗真菌活性的评估。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of novel fluconazoliums were synthesized and their bioactive evaluation as potential antibacterial and antifungal agents were described. Some target compounds displayed good and broad-spectrum antimicrobial activities with low MIC values ranging from 0.25 to 64 mug/mL against all the tested strains, including three Gram-positive bacteria (Staphylococcus aureus, MRSA and Bacillus subtilis), three Gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa and Bacillus proteus) as well as two fungi (Candida albicans and Aspergillus fumigatus). Among all tested title compounds, the octyl, dichlorobenzyl, naphthyl and naphthalimino derivatives gave comparable or even better antibacterial and antifungal efficiency in comparison with the reference drugs Fluconazole, Chloromycin and Norfloxacin.
机译:合成了一系列新型氟康唑,并描述了它们作为潜在的抗菌剂和抗真菌剂的生物活性。一些目标化合物对所有测试菌株均表现出良好的广谱抗菌活性,MIC值低至0.25至64杯/ mL,其中包括三种革兰氏阳性菌(金黄色葡萄球菌,MRSA和枯草芽孢杆菌),三种革兰氏阴性菌(大肠杆菌,铜绿假单胞菌和变形杆菌)以及两种真菌(白色念珠菌和烟曲霉)。在所有测试的标题化合物中,辛基,二氯苄基,萘基和萘二甲酰亚胺衍生物与参考药物氟康唑,绿霉素和诺氟沙星相比具有相当甚至更好的抗菌和抗真菌功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号